| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/08/2010 | WO2010037886A1 Chroman derivatives and uses thereof as inhibitors of the activity of decoupling proteins |
| 04/08/2010 | WO2010037856A2 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 04/08/2010 | WO2010037213A1 Compositions comprising plant extracts and use thereof for treating inflammation |
| 04/08/2010 | WO2010006172A3 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 04/08/2010 | WO2010001096A3 Treatment |
| 04/08/2010 | WO2009129509A4 Methods and compositions for treating post-operative pain comprising a local anesthetic |
| 04/08/2010 | WO2009129453A4 Clonidine formulation in a polyorthoester carrier |
| 04/08/2010 | WO2009053763A8 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/08/2010 | US20100087534 Use of a Photosensitizing Agent in the Treatment or Prevention of an Inflammation-Associated Disorder in the Gastrointestinal Tract of a Mammal |
| 04/08/2010 | US20100087515 Ikk-beta serine-threonine protein kinase inhibitors |
| 04/08/2010 | US20100087502 Indazoles Used To Treat Estrogen Receptor Beta Mediated Disorders |
| 04/08/2010 | US20100087489 Phenyl and Benzodioxinyl Substituted Indazoles Derivatives |
| 04/08/2010 | US20100087480 Substituted phenylmethyl bicyclocarboxyamide compounds |
| 04/08/2010 | US20100087464 Protein kinase inhibitors and methods for using thereof |
| 04/08/2010 | US20100087423 New benzamide derivatives as bradykinin antagonists |
| 04/08/2010 | US20100087392 Complexes of ibuprofen, cyclodextrins and ternary agents and the use thereof in pharmaceutics |
| 04/08/2010 | US20100087386 Topical use of levofloxacin for reducing lung inflammation |
| 04/08/2010 | US20100087385 Application of glycyrrhizic acid and its breakdown product glycyrrhetinic acid for the manufacture of a medicament for the treatment of inflammatory bowel disease |
| 04/08/2010 | US20100086626 Capsaicinoid decontamination compositions and methods of use |
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | US20100086531 METHODS OF MODULATING PROTEIN HOMEOSTASIS, METABOLIC SYNDROME, HEAVY METAL INTOXICATION AND Nrf2 TRANSCRIPTION FACTORS |
| 04/08/2010 | CA2739322A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | CA2739321A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | CA2739083A1 Methods for suppressing toll-like receptor activity |
| 04/08/2010 | CA2738828A1 Novel compounds |
| 04/08/2010 | CA2738827A1 P38 mapk kinase inhibitors |
| 04/08/2010 | CA2738563A1 8-substituted isoquinoline derivatives and the use thereof |
| 04/08/2010 | CA2736914A1 Compositions comprising plant extracts and use thereof for treating inflammation |
| 04/07/2010 | EP2172472A2 Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor |
| 04/07/2010 | EP2172468A1 Benzimidazolone compounds |
| 04/07/2010 | EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound |
| 04/07/2010 | EP2172198A1 p27 PROTEIN INDUCER |
| 04/07/2010 | EP2172197A1 Octanoic acid derivative to treat fibromyalgia and other pains |
| 04/07/2010 | EP2170884A2 Chemical compounds |
| 04/07/2010 | EP2170850A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists |
| 04/07/2010 | EP2170839A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 04/07/2010 | EP2170838A1 Particulates of a crth2 antagonist |
| 04/07/2010 | EP2170826A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 04/07/2010 | EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 04/07/2010 | EP2170364A2 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection |
| 04/07/2010 | EP2170342A1 Compositions and methods for modulating inflammation using fluoroquinolones |
| 04/07/2010 | EP2170311A1 Compounds and methods for treating or preventing autoimmune diseases |
| 04/07/2010 | EP1987010B1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 04/07/2010 | EP1590047B1 Composition comprising lactobacilli or bifidobacteria and use thereof |
| 04/07/2010 | EP1431275B1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/07/2010 | CN1578647B Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 04/07/2010 | CN1571656B Use of lidocaine in preparation of transdermal patch for treating non-neuropathic pain |
| 04/07/2010 | CN101691580A Novel fusion protein for human HMGB1 A box and acidic tail and use thereof |
| 04/07/2010 | CN101690815A Novel use of dipeptidyl peptidase-iv inhibitor |
| 04/07/2010 | CN101690800A Externally used medicament for expelling rheumatism, promoting blood circulation and relieving pain and preparation method thereof |
| 04/07/2010 | CN101690797A Traditional Chinese medicine for treating rheumatism and rheumatoid diseases |
| 04/07/2010 | CN101690788A Throat-clearing three dispersion granules |
| 04/07/2010 | CN101690768A Vein and artery relieving pills for impediment of sinew |
| 04/07/2010 | CN101690757A Method for preparing bezoar supernatant preparations |
| 04/07/2010 | CN101690744A synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
| 04/07/2010 | CN101690739A Preparation method of dogbane leaf extractive |
| 04/07/2010 | CN101690711A Substrate of pain-relieving plaster for injury and rheumatism and preparation method thereof |
| 04/07/2010 | CN101214366B Chinese medicine preparation for treating gout and rheumatism |
| 04/07/2010 | CN100998660B Traditional Chinese medicine plaster for treating vertebral artery type cervical spondylosis and its preparing method |
| 04/06/2010 | US7691974 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
| 04/06/2010 | US7691906 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 04/06/2010 | US7691894 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 04/06/2010 | US7691845 Anti-inflammatory agents |
| 04/06/2010 | US7691841 Azetidine derivatives as CCR-3 receptor antagonist |
| 04/06/2010 | US7691804 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth |
| 04/06/2010 | US7691568 Antibody composition-containing medicament |
| 04/06/2010 | US7691563 Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds |
| 04/06/2010 | US7691425 Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof |
| 04/06/2010 | US7691421 Comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; climacteric disturbance, primary hypogonadism (including ovarian hypofunction and testicular deficiency), Turner's syndrome, Klinefelter's syndrome, gonadotropin-producing tumor, testitis, ovarian amenorrhea |
| 04/06/2010 | US7691387 Cinnamomi and poria composition, method to prepare same and uses thereof |
| 04/06/2010 | CA2513738C Casr antagonist |
| 04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/06/2010 | CA2358505C Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 04/01/2010 | WO2010037092A1 Self-regulating device for modulating inflammation |
| 04/01/2010 | WO2010037059A2 Heteroaryl antagonists of prostaglandin d2 receptors |
| 04/01/2010 | WO2010036632A1 Azaindazole compounds as ccr1 receptor antagonists |
| 04/01/2010 | WO2010036631A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036630A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036065A2 Pharmaceutical composition for preventing and treating inflammatory diseases, containing an ethyl acetate fraction of dried extract of trachelospermi caulis as an active ingredient, and method for producing the fraction |
| 04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
| 04/01/2010 | WO2010035769A1 Improved antibody molecule |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 04/01/2010 | WO2010035299A1 Use of triterpenic and anthraquinone glycosides as substances exerting hydragogue activity on mucosa of the upper respiratory tract, for the treatment of upper respiratory tract diseases |
| 04/01/2010 | WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 04/01/2010 | WO2010034799A1 3h-imidaz0 [4, 5-b] pyridine- 6 -carboxamides as anti -inflammatory agents |
| 04/01/2010 | WO2010034798A1 3h-imidazo [4, 5-c] pyridine-6-carboxamides as anti -inflammatory agents |
| 04/01/2010 | WO2010034797A1 1h-benzimidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | WO2010034796A1 1h-benz imidazole-5-carboxamides as anti-inflammatory agents |
| 04/01/2010 | WO2010034110A1 Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists |
| 04/01/2010 | WO2010017545A3 Triazole compounds that modulate hsp90 activity |
| 04/01/2010 | WO2010017103A3 Fully human anti-human nkg2d monoclonal antibodies |
| 04/01/2010 | WO2010006125A3 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 04/01/2010 | WO2009154944A3 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds |
| 04/01/2010 | WO2009154785A3 C4-substituted alpha-keto oxazoles |
| 04/01/2010 | WO2009151620A9 Pain treatment using erk2 inhibitors |